BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 12652807)

  • 1. [Genetic diagnosis for inherited lung disorders].
    Kanda A; Ueki S; Chihara J
    Rinsho Byori; 2002 Nov; Suppl 123():178-83. PubMed ID: 12652807
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DNA molecular biology in the diagnosis of pulmonary disease.
    Shoemaker SA; Scoggin CH
    Clin Chest Med; 1987 Mar; 8(1):161-71. PubMed ID: 2882884
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The recent progress and future prospects of diagnostic DNA testing--experience in DNA analysis of serum enzymes].
    Sudo K
    Rinsho Byori; 1998 Feb; 46(2):99-106. PubMed ID: 9528332
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular diagnosis of inheritable neuromuscular disorders. Part II: Application of genetic testing in neuromuscular disease.
    Greenberg SA; Walsh RJ
    Muscle Nerve; 2005 Apr; 31(4):431-51. PubMed ID: 15704143
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular diagnosis of inheritable neuromuscular disorders. Part I: Genetic determinants of inherited disease and their laboratory detection.
    Greenberg SA; Walsh RJ
    Muscle Nerve; 2005 Apr; 31(4):418-30. PubMed ID: 15704142
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bottlenecks in molecular testing for rare genetic diseases.
    Willems PJ
    Hum Mutat; 2008 Jun; 29(6):772-5. PubMed ID: 18412107
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The development and clinical implication of genetic tests].
    Nobori T
    Rinsho Byori; 2002 Nov; Suppl 123():1-5. PubMed ID: 12652783
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Scottish molecular genetics consortium--15 years on.
    Kelly KF
    Health Bull (Edinb); 2002 Jan; 60(1):83-90. PubMed ID: 12664773
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Frontier of mycobacterium research--host vs. mycobacterium].
    Okada M; Shirakawa T
    Kekkaku; 2005 Sep; 80(9):613-29. PubMed ID: 16245793
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic contributions to rare childhood lung diseases.
    Jaffé A; Bush A
    Paediatr Respir Rev; 2001 Sep; 2(3):268-75. PubMed ID: 12052329
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Validation of cystic fibrosis mutation analysis using ABI 3130XL genetic analyzer.
    Huang CK; Pan Q
    Diagn Mol Pathol; 2007 Mar; 16(1):57-9. PubMed ID: 17471160
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Introduction to molecular cystic fibrosis testing.
    Uphoff TS; Highsmith WE
    Clin Lab Sci; 2006; 19(1):24-31. PubMed ID: 16617555
    [TBL] [Abstract][Full Text] [Related]  

  • 13. State of the art review: molecular diagnosis of inherited movement disorders. Movement Disorders Society task force on molecular diagnosis.
    Gasser T; Bressman S; Dürr A; Higgins J; Klockgether T; Myers RH
    Mov Disord; 2003 Jan; 18(1):3-18. PubMed ID: 12518296
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Carrier screening for cystic fibrosis in US genetic testing laboratories: a survey of laboratory directors.
    Kaufman DJ; Katsanis SH; Javitt GH; Murphy JA; Scott JA; Hudson KL
    Clin Genet; 2008 Oct; 74(4):367-73. PubMed ID: 18700896
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DNA technological progress toward advanced diagnostic tools to support human hookworm control.
    Gasser RB; Cantacessi C; Loukas A
    Biotechnol Adv; 2008; 26(1):35-45. PubMed ID: 18024057
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular imaging for pediatric lung diseases.
    Richard JC; Chen DL; Ferkol T; Schuster DP
    Pediatr Pulmonol; 2004 Apr; 37(4):286-96. PubMed ID: 15022124
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular diagnostics in hemostatic disorders.
    Perrotta PL; Svensson AM
    Clin Lab Med; 2009 Jun; 29(2):367-90. PubMed ID: 19665683
    [TBL] [Abstract][Full Text] [Related]  

  • 18. American Society of Clinical Oncology policy statement update: genetic testing for cancer susceptibility.
    American Society of Clinical Oncology
    J Clin Oncol; 2003 Jun; 21(12):2397-406. PubMed ID: 12692171
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adoption of array technologies into the clinical laboratory.
    Hadd AG; Brown JT; Andruss BF; Ye F; WalkerPeach CR
    Expert Rev Mol Diagn; 2005 May; 5(3):409-20. PubMed ID: 15934817
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gene modifiers of lung disease.
    Knowles MR
    Curr Opin Pulm Med; 2006 Nov; 12(6):416-21. PubMed ID: 17053491
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.